Smith & Nephew SNATS Operating Income 2010-2024 | SNN

Smith & Nephew SNATS annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Smith & Nephew SNATS operating income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS operating income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS annual operating income for 2024 was $0.657B, a 54.59% increase from 2023.
  • Smith & Nephew SNATS annual operating income for 2023 was $0.425B, a 5.56% decline from 2022.
  • Smith & Nephew SNATS annual operating income for 2022 was $0.45B, a 24.11% decline from 2021.
Smith & Nephew SNATS Annual Operating Income
(Millions of US $)
2024 $657
2023 $425
2022 $450
2021 $593
2020 $295
2019 $815
2018 $863
2017 $934
2016 $801
2015 $628
2014 $749
2013 $810
2012 $846
2011 $862
2010 $920
2009 $723
Smith & Nephew SNATS Quarterly Operating Income
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31 $226
2014-09-30 $160
2014-06-30 $134
2014-03-31 $229
2013-12-31 $235
2013-09-30 $180
2013-06-30 $188
2013-03-31 $207
2012-12-31 $213
2012-09-30 $187
2012-06-30 $210
2012-03-31 $236
2011-12-31 $214
2011-09-30 $191
2011-06-30 $226
2011-03-31 $231
2010-12-31 $267
2010-09-30 $206
2010-06-30 $207
2010-03-31 $240
2009-12-31 $189
2009-09-30 $186
2009-06-30 $189
2009-03-31 $159
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.253B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.407B 27.95
Boston Scientific (BSX) United States $151.037B 37.81
Stryker (SYK) United States $146.527B 30.64
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $112.146B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.313B 0.00
Haleon (HLN) United Kingdom $49.826B 28.39
ResMed (RMD) United States $36.979B 27.77
Agilent Technologies (A) United States $32.895B 21.44
GE HealthCare Technologies (GEHC) United States $32.794B 15.57
Terumo (TRUMY) Japan $26.561B 34.50
Koninklijke Philips (PHG) Netherlands $22.051B 15.85
Insulet (PODD) United States $21.941B 86.12
Zimmer Biomet Holdings (ZBH) United States $18.277B 11.74
Baxter (BAX) United States $15.529B 11.59
Demant (WILYY) Denmark $8.854B 0.00
Sunny Optical Technology (SNPTF) China $8.430B 0.00
Bio-Rad Laboratories (BIO) United States $5.971B 20.78
Lantheus Holdings (LNTH) United States $5.642B 14.23
Prestige Consumer Healthcare (PBH) United States $4.203B 18.78
Perrigo (PRGO) Ireland $3.596B 9.11
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.385B 15.42
ICU Medical (ICUI) United States $3.275B 24.15
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $1.997B 13.73
LeMaitre Vascular (LMAT) United States $1.901B 42.49
AtriCure (ATRC) United States $1.730B 0.00
Acuren (TIC) United States $1.271B 0.00
AdaptHealth (AHCO) United States $1.201B 12.19
Neogen (NEOG) United States $1.131B 14.47
BioLife Solutions (BLFS) United States $1.126B 0.00
Green Thumb Industries (GTBIF) United States $1.100B 24.74
Kestra Medical Technologies (KMTS) United States $1.063B 0.00
Phibro Animal Health (PAHC) United States $0.976B 12.48
InMode (INMD) Israel $0.895B 9.02
Capricor Therapeutics (CAPR) United States $0.650B 0.00
Evolus (EOLS) United States $0.647B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Owens & Minor (OMI) United States $0.619B 5.13
Maravai LifeSciences Holdings (MRVI) United States $0.609B 0.00
Curaleaf Holdings (CURLF) Canada $0.584B 0.00
Valneva SE (VALN) France $0.524B 0.00
Surmodics (SRDX) United States $0.420B 0.00
Tilray Brands (TLRY) Canada $0.408B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.76
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.322B 57.20
Canopy Growth (CGC) Canada $0.313B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.289B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Cresco Labs (CRLBF) United States $0.265B 0.00
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 11.87
Sanuwave Health (SNWV) United States $0.239B 0.00
Omeros (OMER) United States $0.221B 0.00
OraSure Technologies (OSUR) United States $0.216B 0.00
Biote (BTMD) United States $0.210B 5.89
Quanterix (QTRX) United States $0.209B 0.00
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Brainsway (BWAY) Israel $0.197B 52.25
High Tide (HITI) Canada $0.193B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.86
Organigram Global (OGI) Canada $0.181B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Jin Medical (ZJYL) China $0.120B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.59
Quipt Home Medical (QIPT) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.082B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.038B 13.14
Nephros (NEPH) United States $0.036B 48.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00